NO331198B1 - Anvendelse av LHRH-antagonist for fremstilling av et medikament til terapeutisk styring av ekstrauterin proliferering av endometrievev, kronisk bekkensmerte og egglederobstruksjon - Google Patents
Anvendelse av LHRH-antagonist for fremstilling av et medikament til terapeutisk styring av ekstrauterin proliferering av endometrievev, kronisk bekkensmerte og egglederobstruksjonInfo
- Publication number
- NO331198B1 NO331198B1 NO20021430A NO20021430A NO331198B1 NO 331198 B1 NO331198 B1 NO 331198B1 NO 20021430 A NO20021430 A NO 20021430A NO 20021430 A NO20021430 A NO 20021430A NO 331198 B1 NO331198 B1 NO 331198B1
- Authority
- NO
- Norway
- Prior art keywords
- drug
- manufacture
- fallopian tube
- pelvic pain
- chronic pelvic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15547899P | 1999-09-23 | 1999-09-23 | |
| PCT/EP2000/009212 WO2001021194A2 (en) | 1999-09-23 | 2000-09-20 | Method for the therapeutic management of endometriosis and fallopian tube obstruction |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20021430D0 NO20021430D0 (no) | 2002-03-21 |
| NO20021430L NO20021430L (no) | 2002-05-07 |
| NO331198B1 true NO331198B1 (no) | 2011-10-31 |
Family
ID=22555601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20021430A NO331198B1 (no) | 1999-09-23 | 2002-03-21 | Anvendelse av LHRH-antagonist for fremstilling av et medikament til terapeutisk styring av ekstrauterin proliferering av endometrievev, kronisk bekkensmerte og egglederobstruksjon |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1214086A2 (ja) |
| JP (2) | JP2003509467A (ja) |
| KR (1) | KR100772852B1 (ja) |
| CN (2) | CN101045155A (ja) |
| AU (1) | AU769482B2 (ja) |
| BG (1) | BG66128B1 (ja) |
| BR (1) | BR0014198A (ja) |
| CA (1) | CA2383510A1 (ja) |
| HK (1) | HK1049117A1 (ja) |
| HU (1) | HUP0202741A3 (ja) |
| IL (1) | IL148185A0 (ja) |
| MX (1) | MXPA02002436A (ja) |
| NO (1) | NO331198B1 (ja) |
| NZ (1) | NZ534836A (ja) |
| PL (1) | PL201898B1 (ja) |
| RU (1) | RU2255759C2 (ja) |
| SK (1) | SK3752002A3 (ja) |
| TR (1) | TR200200738T2 (ja) |
| TW (1) | TWI267373B (ja) |
| UA (1) | UA73956C2 (ja) |
| WO (1) | WO2001021194A2 (ja) |
| ZA (1) | ZA200201374B (ja) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10157628A1 (de) * | 2001-11-26 | 2003-06-12 | Zentaris Ag | Injektionslösung eines LHRH-Antagonisten |
| US7214662B2 (en) | 2001-11-27 | 2007-05-08 | Zentaris Gmbh | Injectable solution of an LHRH antagonist |
| PT2252627T (pt) | 2008-01-24 | 2017-07-24 | Esperance Pharmaceuticals | Constructos de fusão de domínio lítico e métodos para produzir e utilizar os mesmos |
| EP2379099A1 (en) * | 2009-01-22 | 2011-10-26 | Maatschap Interne Geneeskunde Rijnstate | Method for the prophylaxis or treatment of flushing |
| KR102460297B1 (ko) | 2012-10-30 | 2022-10-28 | 에스퍼란스 파마슈티컬스, 인코포레이티드 | 항체/약물 컨쥬게이트 및 이의 사용 방법 |
| CA2906894A1 (en) | 2013-03-15 | 2014-09-18 | Abbvie Inc. | Compositions comprising elagolix for use in treating pain associated with endometriosis |
| WO2019036713A1 (en) | 2017-08-18 | 2019-02-21 | Abbvie Inc. | SOLID PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF ENDOMETRIOSIS, UTERINE FIBROIDS, POLYKYSTIC OVARY SYNDROME AND ADENOMYOSIS |
| JP7374885B2 (ja) | 2017-08-18 | 2023-11-07 | アッヴィ・インコーポレイテッド | 子宮内膜症、子宮筋腫、多嚢胞性卵巣症候群又は腺筋症を治療するための医薬製剤 |
| CA3097340A1 (en) | 2018-04-19 | 2019-10-24 | Abbvie Inc. | Methods of treating heavy menstrual bleeding |
| EP3560555A1 (en) * | 2018-04-26 | 2019-10-30 | LifeArc | A composition for treating one or more estrogen related diseases |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5064939A (en) * | 1990-02-06 | 1991-11-12 | The Salk Institute For Biological Studies | Cyclic gnrh antagonists |
| SE9301606D0 (sv) * | 1993-05-07 | 1993-05-07 | Per-Christer Oden | Composition for the treatment of impaired hair growth |
| US5658884A (en) * | 1994-07-22 | 1997-08-19 | The Medical College Of Hampton Roads | Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
| IL114655A (en) * | 1994-07-22 | 2005-08-31 | Hampton Roads Medical College | USE OF GnRH ANTAGONIST IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF A GONADAL-STEROID DEPENDENT CONDITION IN A MAMMAL |
| DE19513662A1 (de) * | 1995-04-08 | 1996-10-10 | Schering Ag | Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption |
| DE19604231A1 (de) * | 1996-01-29 | 1997-07-31 | Schering Ag | Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen |
| EP0943336A1 (en) * | 1996-09-04 | 1999-09-22 | Dott Research Laboratory | Peptide-containing pharmaceutical compositions for oral administration |
| CA2292605A1 (en) * | 1997-06-05 | 1998-12-10 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| DE19911771B4 (de) * | 1999-03-17 | 2006-03-30 | Zentaris Gmbh | LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung |
-
2000
- 2000-09-20 UA UA2002043346A patent/UA73956C2/uk unknown
- 2000-09-20 CN CNA2007100789192A patent/CN101045155A/zh active Pending
- 2000-09-20 BR BR0014198-4A patent/BR0014198A/pt not_active Application Discontinuation
- 2000-09-20 SK SK375-2002A patent/SK3752002A3/sk not_active Application Discontinuation
- 2000-09-20 CN CN00813196A patent/CN1376070A/zh active Pending
- 2000-09-20 CA CA002383510A patent/CA2383510A1/en not_active Abandoned
- 2000-09-20 EP EP00967722A patent/EP1214086A2/en not_active Withdrawn
- 2000-09-20 NZ NZ534836A patent/NZ534836A/en not_active IP Right Cessation
- 2000-09-20 HU HU0202741A patent/HUP0202741A3/hu unknown
- 2000-09-20 AU AU77792/00A patent/AU769482B2/en not_active Ceased
- 2000-09-20 WO PCT/EP2000/009212 patent/WO2001021194A2/en active IP Right Grant
- 2000-09-20 JP JP2001524618A patent/JP2003509467A/ja not_active Withdrawn
- 2000-09-20 MX MXPA02002436A patent/MXPA02002436A/es active IP Right Grant
- 2000-09-20 PL PL353244A patent/PL201898B1/pl not_active IP Right Cessation
- 2000-09-20 RU RU2002111000/14A patent/RU2255759C2/ru not_active IP Right Cessation
- 2000-09-20 IL IL14818500A patent/IL148185A0/xx not_active IP Right Cessation
- 2000-09-20 TR TR2002/00738T patent/TR200200738T2/xx unknown
- 2000-09-20 KR KR1020027003740A patent/KR100772852B1/ko not_active IP Right Cessation
- 2000-09-22 TW TW089119671A patent/TWI267373B/zh not_active IP Right Cessation
-
2002
- 2002-02-19 ZA ZA200201374A patent/ZA200201374B/en unknown
- 2002-03-21 NO NO20021430A patent/NO331198B1/no not_active IP Right Cessation
- 2002-04-05 BG BG106584A patent/BG66128B1/bg unknown
-
2003
- 2003-02-18 HK HK03101215.4A patent/HK1049117A1/zh unknown
-
2011
- 2011-10-17 JP JP2011227603A patent/JP2012051920A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU769482B2 (en) | 2004-01-29 |
| SK3752002A3 (en) | 2003-06-03 |
| WO2001021194A3 (en) | 2002-03-14 |
| HUP0202741A2 (hu) | 2003-01-28 |
| MXPA02002436A (es) | 2003-02-12 |
| HUP0202741A3 (en) | 2003-12-29 |
| CN101045155A (zh) | 2007-10-03 |
| BG66128B1 (bg) | 2011-06-30 |
| NZ534836A (en) | 2007-07-27 |
| ZA200201374B (en) | 2002-10-30 |
| EP1214086A2 (en) | 2002-06-19 |
| CN1376070A (zh) | 2002-10-23 |
| JP2012051920A (ja) | 2012-03-15 |
| KR100772852B1 (ko) | 2007-11-02 |
| TR200200738T2 (tr) | 2002-08-21 |
| PL201898B1 (pl) | 2009-05-29 |
| HK1049117A1 (zh) | 2003-05-02 |
| IL148185A0 (en) | 2002-09-12 |
| PL353244A1 (en) | 2003-11-03 |
| AU7779200A (en) | 2001-04-24 |
| KR20020035879A (ko) | 2002-05-15 |
| NO20021430D0 (no) | 2002-03-21 |
| RU2255759C2 (ru) | 2005-07-10 |
| CA2383510A1 (en) | 2001-03-29 |
| WO2001021194A2 (en) | 2001-03-29 |
| JP2003509467A (ja) | 2003-03-11 |
| BR0014198A (pt) | 2002-05-21 |
| TWI267373B (en) | 2006-12-01 |
| NO20021430L (no) | 2002-05-07 |
| BG106584A (bg) | 2003-02-28 |
| UA73956C2 (en) | 2005-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL158306A0 (en) | Pharmaceutical dosage form of amorphous nelfinavir mesylate | |
| DK1242055T3 (da) | Hydrogelstyret doseringsform til lægemidler | |
| IL150657A0 (en) | Multi-step drug dosage forms | |
| NO20015797L (no) | Indazolforbindelser og farmasöytiske forbindelser for inhibering av proteinkinaser, og fremgangsmåter til anvendelsederav | |
| IL154012A0 (en) | Hydrogel-driven drug dosage form | |
| HUP0302544A3 (en) | Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors | |
| GB0117618D0 (en) | Pharmaceutical dosage form | |
| NO20021400L (no) | Terapeutiske kinazolinderivater | |
| AU7528101A (en) | A device for delivering a therapeutic dosage | |
| NO20042208L (no) | Vaginalt administrerte anti-dysrytmiske midler for behandling av bekkensmerter | |
| NO331198B1 (no) | Anvendelse av LHRH-antagonist for fremstilling av et medikament til terapeutisk styring av ekstrauterin proliferering av endometrievev, kronisk bekkensmerte og egglederobstruksjon | |
| GB0117619D0 (en) | Pharmaceutical dosage form | |
| NO20021094D0 (no) | Profylaktiske og terapeutiske medikamenter for oftalmologiske sykdommer | |
| IL159345A0 (en) | Active ingredient combination for pharmacological addictive substances or intoxicant therapy | |
| AU2001264920A1 (en) | Therapeutic uses of il-1 receptor antagonist | |
| IL151922A0 (en) | Transdermal therapeutic system for the delivery of lerisetron | |
| AU2001228656A1 (en) | Antagonist of th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases | |
| AU2003220523A8 (en) | Platelet-activating factor antagonists as analgesic, anti-inflammatory, uterine contraction inhibiting, and anti-tumor agents | |
| NO20032006L (no) | Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser | |
| SI1390063T1 (en) | Pharmaceutical dosage form of amorphous nelfinavir mesylate | |
| DK1897944T3 (da) | IL-17 homologe polypeptider og terapeutisk anvendelse deraf | |
| IL149853A0 (en) | Gastroretentive controlled release pharmaceutical dosage forms | |
| IL128582A0 (en) | Pharmaceutical dosage form | |
| IL153219A0 (en) | A device for delivering a therapeutic dosage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |